Effects of CPAP on cholesterol and uric acid levels in patients with sleep apnea and high cholesterol
Official title: Effect of 12 Months of Treatment With Continuous Positive Airway Pressure on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea. A Randomized, Open-labell, Parallel Clinical Trial
Run by Hospital Universitario La Paz · NCT06463561 · Data updated 2026-11-12
This study tests if using a CPAP machine for a year can help people with sleep apnea and high cholesterol lower their cholesterol and uric acid levels while also improving their overall health.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 35 Years to 80 Years |
| Sex | All |
| Enrollment | 220 (estimated) |
| Sponsor | Hospital Universitario La Paz Academic / other |
| Locations | 1 site (Coslada, Madrid) |
| Status | Recruiting |
| Started | July 12, 2024 |
| Main results expected | July 30, 2027 |
| Study ends | January 31, 2028 |
| Registry record updated | July 15, 2024 |
| Trial ID | NCT06463561 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 35 to 80 with a diagnosis of dyslipidemia and moderate to severe obstructive sleep apnea.
✕Probably not a fit
Patients with central sleep apnea or those already indicated for CPAP treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the impact of 12 months of continuous positive airway pressure (CPAP) treatment combined with standard pharmacological therapy on the lipid profiles and serum uric acid levels in patients suffering from moderate to severe obstructive sleep apnea and dyslipidemia. The study aims to assess not only improvements in lipid profiles but also the effects on insulin resistance, cardiovascular risk, glycemic control, and inflammation markers. Participants will receive hygienic-dietary recommendations and be encouraged to engage in daily physical activity as part of their treatment regimen.
Why it matters
Potential benefit: If successful, this study could lead to improved management of lipid levels and reduced cardiovascular risks for patients with sleep apnea and dyslipidemia.
How similar studies have gone: Previous studies have shown promising results in improving health outcomes with CPAP treatment in similar patient populations, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects from 35 to 80 years old * Diagnosis of dyslipidemia. It will be considered as such, the existence of a previous clinical record of a diagnosis of dyslipidemia associated with treatment with lipidlowering agents, treatment with lipid-lowering agents or the presence of an altered blood test in the last two months, using the following cut-off points: total cholesterol ≥ 200 mg/dl, triglycerides ≥ 180 mg/dl, HDL-cholesterol ≤ 40 mg/dl or LDL-cholesterol ≥ 150 mg/dl. * Moderate-severe sleep apnea, defined by AHI \> 15 h-1 . Exclusion Criteria: * Predominance of central apneas-hypopneas, defined as more than 25% of total respiratory events. * Patients with indications for CPAP treatment according to the International Sleep Consensus: hypertensive, excessive daytime sleepiness (Epworth Sleepiness Scale \> 11) or impaired sleep-related quality of life considered relevant by their regular physician. * Professional drivers, at-risk profession or respiratory insufficiency (according to criteria of the clinical pathway for the diagnosis and treatment of sleep-disordered breathing). * Pretreatment with CPAP
Where it's running
-
Hospital Universitario del Henares
Coslada, Madrid, Spain Recruiting
Study contacts
- Principal investigator: Ana De la Rocha Prieto, MD — Hospital Universitario del Henares
- Study coordinator: Francisco Garcia-Rio, MD
- Email: fgr01m@gmail.com
- Phone: +34639911718
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Oura Ring validation for sleep using gold-standard sleep tests
This study tests how well the Oura Ring matches the gold-standard sleep test ( PSG ) in healthy adults and people with sleep apnea.
-
Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities
This study tests how comorbid conditions like sleep apnea and primary aldosteronism relate to left-atrial fibrosis and AF recurrence in patients undergoing ablation.
-
Hyperuricemia and gum disease: is uric acid linked to bone loss in periodontitis?
This observational study tests whether high uric acid levels are related to periodontitis and alveolar bone loss in adults.
-
Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala
This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.
-
Group visits to help manage high cholesterol
This project will try group medical visits for adults with dyslipidemia to see if they improve care, lifestyle habits, and access to primary care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.